Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of -4.47 is 77% above its 5-year average of -19.34, near the high end of its 5-year range (-34.46–-4.47).
59.53% above its 12-month average of -11.04.
Reported quarterly EPS; no daily interpolation. Q2 FY2026 (2026-06-30): -0.63.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 20 comparable quarters.
EARNINGS PER SHARE (EPS)
-4.47
EARNINGS PER SHARE (EPS) AVG TTM
-11.04
EARNINGS PER SHARE (EPS) AVG 3Y
-20.14
EARNINGS PER SHARE (EPS) AVG 5Y
-19.34
EARNINGS PER SHARE (EPS) AVG 10Y
N/A
EARNINGS PER SHARE (EPS) AVG 15Y
N/A
EARNINGS PER SHARE (EPS) AVG 20Y
N/A
CURRENT VS TTM AVG
+59.53%
CURRENT VS 3Y AVG
+77.80%
CURRENT VS 5Y AVG
+76.89%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Instil Bio, Inc.
Market Cap
$47.09M
Earnings Per Share (EPS)
-4.47
TTM Avg
-11.04
3Y Avg
-20.14
5Y Avg
-19.34
Market Cap
$47.47M
Earnings Per Share (EPS)
-9.11
TTM Avg
-2.23
3Y Avg
-1.64
5Y Avg
-3.32
Market Cap
$48.76M
Earnings Per Share (EPS)
-0.26
TTM Avg
-0.51
3Y Avg
-0.97
5Y Avg
-1.13
Market Cap
$49.50M
Earnings Per Share (EPS)
N/A
TTM Avg
-30.18
3Y Avg
-88.49
5Y Avg
-66.35
Market Cap
$45.16M
Earnings Per Share (EPS)
-2.83
TTM Avg
-3.12
3Y Avg
-4.06
5Y Avg
-22.86
Market Cap
$49.06M
Earnings Per Share (EPS)
-0.94
TTM Avg
-0.03
3Y Avg
0.36
5Y Avg
0.21
Market Cap
$45.05M
Earnings Per Share (EPS)
0.69
TTM Avg
-0.78
3Y Avg
-1.53
5Y Avg
-2.71
Market Cap
$45.02M
Earnings Per Share (EPS)
0.90
TTM Avg
-2.83
3Y Avg
-6.22
5Y Avg
-12.54
Market Cap
$49.21M
Earnings Per Share (EPS)
-0.77
TTM Avg
-1.08
3Y Avg
-1.73
5Y Avg
-1.91
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Instil Bio, Inc. (TIL) | $47.09M | -4.47 | -11.04 | -20.14 | -19.34 |
| Lite Strategy, Inc. (LITS)vs › | $47.47M | -9.11 | -2.23 | -1.64 | -3.32 |
| Microbot Medical Inc. (MBOT)vs › | $48.76M | -0.26 | -0.51 | -0.97 | -1.13 |
| Apollomics, Inc. (APLM)vs › | $49.50M | N/A | -30.18 | -88.49 | -66.35 |
| Celularity Inc. (CELU)vs › | $45.16M | -2.83 | -3.12 | -4.06 | -22.86 |
| Sensus Healthcare, Inc. (SRTS)vs › | $49.06M | -0.94 | -0.03 | 0.36 | 0.21 |
| DarioHealth Corp. (DRIO)vs › | $45.05M | 0.69 | -0.78 | -1.53 | -2.71 |
| SANUWAVE Health Inc. (SNWV)vs › | $45.02M | 0.90 | -2.83 | -6.22 | -12.54 |
| TELA Bio, Inc. (TELA)vs › | $49.21M | -0.77 | -1.08 | -1.73 | -1.91 |
| Werewolf Therapeutics, Inc. (HOWL)vs › | $45.07M | -0.73 | -1.48 | -1.47 | -1.37 |
Trailing EPS (TTM)
$-4.47
Forward EPS (Est.)
$-1.17
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | -10.70 |
| 2024-12-31 | -11.39 |
| 2023-12-31 | -24.00 |
| 2022-12-31 | -34.46 |
| 2021-12-31 | -29.60 |
| 2020-12-31 | -5.89 |
| 2019-12-31 | -1.01 |
